Diagnosis of chronic diarrhoea with lactose intolerance is a dubious disease in the area of infectious respiratory digestive and endocrine disorders, clinical manifestations are complex and often involve multi-system fatigue. Early identification and standardized clinical treatment are essential for improving prognosis. Diagnosis of the disease requires a combination of clinical manifestations, imaging inspections, laboratory tests and pathological biopsies.
The platform can assist in matching a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Individualised development of treatment programs for the treatment and management of chronic diarrhoea with lactose intolerance, usually including drug therapy, convalescence, regular follow-up, and other multidimensional management needs. In recent years, with the development of treatment-oriented, immune-regulatory treatments and precision medicine, many previously difficult to treat infectious respiratory digestive endocrine diseases have improved significantly.
Therapeutic efficacy and adverse reactions need to be closely monitored and timely adjusted according to changes in the disease. Multidisciplinary collaboration MDT is particularly important for the comprehensive management of lactose intolerance with chronic diarrhoea. The platform serves the China International Medical Service System, which combines domestic and foreign authoritative teams of experts in the field of infectious respiratory digestive and endocrine secretion to provide the following services to patients: 1.
Remote pre-diagnosis: pre-examination of medical records, precise diagnostic directions and medical advice by the team of experts; 2. Interviews in China: arrangements with authoritative experts for face-to-face diagnosis, development of personalized treatment programs; 3. Full-service: one-stop services: medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishment of a chronic disease management file, continuous monitoring of changes in disease and treatment effects. Support for remote pre-diagnosis, visiting interviews, full translation and escort.